Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFM0A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,214
Award facts
- Contract value 100% obligated
- $49,213.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $49,213.66 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3ml vials. This is a firm fixed-price, non-set-aside contract with a completion date of February 2, 2026, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, which carries a potential value of $999,999,999.00 through December 31, 2031, and serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen is a major pharmaceutical distributor that supplies critical medications across multiple therapeutic domains to federal healthcare systems, including the military and Veterans Affairs. This award reflects the company's continued role as a key vendor within DLA's Medical Supply Chain, providing essential pharmaceutical commodities to support military treatment facilities and other federal medical institutions. The contract demonstrates the competitive procurement process used by DLA Troop Support Medical to source specialty medications like Ozempic, a diabetes treatment, which is essential for managing chronic conditions among the military population and veteran healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FFM0A?
SPE2DR26FFM0A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FFM0A worth?
The government has obligated $49,214 on SPE2DR26FFM0A.
Is contract SPE2DR26FFM0A an order under another contract?
Yes. SPE2DR26FFM0A is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFM0A competed?
The extent of competition for SPE2DR26FFM0A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award